0.0360
+0.0040
+(12.50%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-3,064.0700
-3,228.1370
-4,386.6940
-4,876.3410
-3,359.5540
Investing Cash Flow
-735.9070
-650.4310
-3,174.7450
-582.7420
-201.5480
Financing Cash Flow
252.4680
-206.9480
-114.1630
451.7620
32,783.1270
End Cash Position
12,816.1610
14,372.3240
18,486.6440
26,093.7380
31,185.4870
Capital Expenditure
-759.6960
-693.8130
-2,064.3670
-406.9940
-267.8990
Issuance of Capital Stock
--
--
--
--
25,071.8180
Repayment of Debt
-232.8030
-220.1330
-164.1630
-88.0780
-18.9250
Repurchase of Capital Stock
-73.5550
-88.8150
--
--
--
Free Cash Flow
-3,823.7660
-3,921.9500
-6,451.0610
-5,283.3350
-3,627.4530
3/31/2021 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYCOF Mydecine Innovations Group Inc.
0.0040
0.00%
OPTI.CN Optimi Health Corp.
0.2300
+6.98%
PHRX.CN Pharmadrug Inc.
0.0150
0.00%
183490.KQ Enzychem Lifesciences Corporation
1,540.00
+2.67%
AIHLF Adcock Ingram Holdings Limited
2.4500
0.00%
ALID Allied Corp.
0.0348
0.00%
RVVTF Revive Therapeutics Ltd.
0.0060
0.00%
FLHLF Filament Health Corp.
0.0343
0.00%
CANSF Willow Biosciences Inc.
0.0200
0.00%
FLWPF THE FLOWR CORPORATION
0.0190
+17,587,050.00%